Keiko Murase

479 total citations
21 papers, 354 citations indexed

About

Keiko Murase is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Keiko Murase has authored 21 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 14 papers in Cancer Research and 8 papers in Molecular Biology. Recurrent topics in Keiko Murase's work include Breast Cancer Treatment Studies (13 papers), HER2/EGFR in Cancer Research (8 papers) and Cancer Cells and Metastasis (4 papers). Keiko Murase is often cited by papers focused on Breast Cancer Treatment Studies (13 papers), HER2/EGFR in Cancer Research (8 papers) and Cancer Cells and Metastasis (4 papers). Keiko Murase collaborates with scholars based in Japan, Finland and United States. Keiko Murase's co-authors include Yasuo Miyoshi, Michiko Imamura, Yoshimasa Miyagawa, Yuichi Takatsuka, Ayako Yanai, Masaru Saito, Arisa Nishimukai, Tomoko Higuchi, Tomoko Yagi and Seiichi Hirota and has published in prestigious journals such as Breast Cancer Research and Treatment, Human Mutation and Molecular Genetics and Metabolism.

In The Last Decade

Keiko Murase

20 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Keiko Murase Japan	12	158	150	140	70	57	21	354
Sunao Tanaka Japan	10	98 0.6×	184 1.2×	107 0.8×	22 0.3×	26 0.5×	26	328
Raquel Buj United States	11	73 0.5×	236 1.6×	89 0.6×	15 0.2×	36 0.6×	16	351
G.P. Boland United Kingdom	7	224 1.4×	96 0.6×	167 1.2×	89 1.3×	138 2.4×	8	417
Melissa Lazar United States	9	84 0.5×	108 0.7×	105 0.8×	67 1.0×	14 0.2×	27	296
Kailas Munot United Kingdom	4	104 0.7×	117 0.8×	87 0.6×	65 0.9×	127 2.2×	8	272
Donghui Li China	6	212 1.3×	211 1.4×	150 1.1×	54 0.8×	59 1.0×	8	438
Mark D. McKee United States	7	137 0.9×	80 0.5×	107 0.8×	47 0.7×	13 0.2×	9	259
Maria Giuseppa Sarobba Italy	10	194 1.2×	137 0.9×	147 1.1×	26 0.4×	63 1.1×	18	344
Janani Jayanthan Australia	6	147 0.9×	79 0.5×	107 0.8×	52 0.7×	20 0.4×	8	264
TaeJeong Oh South Korea	10	120 0.8×	210 1.4×	97 0.7×	75 1.1×	28 0.5×	14	385

Countries citing papers authored by Keiko Murase

Since Specialization

Citations

This map shows the geographic impact of Keiko Murase's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keiko Murase with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keiko Murase more than expected).

Fields of papers citing papers by Keiko Murase

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keiko Murase. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keiko Murase. The network helps show where Keiko Murase may publish in the future.

Co-authorship network of co-authors of Keiko Murase

This figure shows the co-authorship network connecting the top 25 collaborators of Keiko Murase. A scholar is included among the top collaborators of Keiko Murase based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keiko Murase. Keiko Murase is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nagahashi, Masayuki, Eri Ishikawa, Takahiro Nagai, et al.. (2025). Clinical utility of tumor-infiltrating lymphocyte evaluation by two different methods in breast cancer patients treated with neoadjuvant chemotherapy. Breast Cancer. 32(2). 404–415.

Nagahashi, Masayuki, Akira Hattori, Junko Tsuchida, et al.. (2024). Neutrophil-to-lymphocyte ratio at the end of treatment with CDK4/6 inhibitors is an independent prognostic factor for ER-positive HER2-negative advanced breast cancer. International Journal of Clinical Oncology. 29(12). 1850–1859. 3 indexed citations

Imamura, Michiko, Takashi Morimoto, Takashi Nomura, et al.. (2018). Independent prognostic impact of preoperative serum carcinoembryonic antigen and cancer antigen 15-3 levels for early breast cancer subtypes. World Journal of Surgical Oncology. 16(1). 26–26. 21 indexed citations

Higuchi, Tomoko, Arisa Nishimukai, Yukie Fujimoto, et al.. (2016). Prognostic significance of preoperative 18F-FDG PET/CT for breast cancer subtypes. The Breast. 30. 5–12. 31 indexed citations

Nishimukai, Arisa, Tomoko Higuchi, Ayako Yanai, et al.. (2016). Different patterns of change in bone turnover markers during treatment with bone-modifying agents for breast cancer patients with bone metastases. Breast Cancer. 24(2). 245–253. 6 indexed citations

Imamura, Michiko, Arisa Nishimukai, Tomoko Higuchi, et al.. (2015). High levels at baseline of serum pyridinoline crosslinked carboxyterminal telopeptide of type I collagen are associated with worse prognosis for breast cancer patients. Breast Cancer Research and Treatment. 154(3). 521–531. 5 indexed citations

Morimoto, Takashi, Arisa Nishimukai, Tomoko Higuchi, et al.. (2015). Impact of biomarker changes during neoadjuvant chemotherapy for clinical response in patients with residual breast cancers. International Journal of Clinical Oncology. 21(2). 254–261. 21 indexed citations

Yagi, Tomoko, Natsuko Inoue, Ayako Yanai, et al.. (2014). Prognostic significance of geminin expression levels in Ki67-high subset of estrogen receptor-positive and HER2-negative breast cancers. Breast Cancer. 23(2). 224–230. 10 indexed citations

Nishimukai, Arisa, Tomoko Yagi, Ayako Yanai, et al.. (2014). High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer. Clinical Breast Cancer. 15(3). 204–211. 35 indexed citations

10.

Yanai, Ayako, Natsuko Inoue, Tomoko Yagi, et al.. (2014). Activation of mTOR/S6K But Not MAPK Pathways Might Be Associated With High Ki-67, ER+, and HER2− Breast Cancer. Clinical Breast Cancer. 15(3). 197–203. 18 indexed citations

11.

Miyake, Tomohiro, Takashi Ito, Ayako Yanai, et al.. (2013). C4.4A highly expressed in HER2-positive human breast cancers may indicate a good prognosis. Breast Cancer. 22(4). 366–373. 6 indexed citations

12.

Yanai, Ayako, Yoshimasa Miyagawa, Keiko Murase, et al.. (2013). Influence of body mass index on clinicopathological factors including estrogen receptor, progesterone receptor, and Ki67 expression levels in breast cancers. International Journal of Clinical Oncology. 19(3). 467–472. 15 indexed citations

13.

Miyagawa, Yoshimasa, Tomohiro Miyake, Ayako Yanai, et al.. (2013). Association of body mass index with risk of luminal A but not luminal B estrogen receptor-positive and HER2-negative breast cancer for postmenopausal Japanese women. Breast Cancer. 22(4). 399–405. 11 indexed citations

14.

Fukao, Toshiyuki, Yuka Aoyama, Keiko Murase, et al.. (2013). Development of MLPA for human ACAT1 gene and identification of a heterozygous Alu-mediated deletion of exons 3 and 4 in a patient with mitochondrial acetoacetyl-CoA thiolase (T2) deficiency. Molecular Genetics and Metabolism. 110(1-2). 184–187. 8 indexed citations

15.

Murase, Keiko, Ayako Yanai, Masaru Saito, et al.. (2012). Biological characteristics of luminal subtypes in pre- and postmenopausal estrogen receptor-positive and HER2-negative breast cancers. Breast Cancer. 21(1). 52–57. 11 indexed citations

16.

Hori, Tomohiro, Toshiyuki Fukao, Keiko Murase, et al.. (2012). Molecular Basis of Two-Exon Skipping (Exons 12 and 13) by c.1248+5g>a inOXCT1Gene: Study on Intermediates ofOXCT1Transcripts in Fibroblasts. Human Mutation. 34(3). 473–480. 23 indexed citations

17.

Miyoshi, Yasuo, et al.. (2010). Mechanisms of estrogen receptor-α upregulation in breast cancers. Medical Molecular Morphology. 43(4). 193–196. 35 indexed citations

18.

Miyoshi, Yasuo, et al.. (2009). Prediction of hormone sensitivity for breast cancers. Breast Cancer. 17(2). 86–91. 14 indexed citations

19.

Miyoshi, Yasuo, et al.. (2008). Basal-like subtype and BRCA1 dysfunction in breast cancers. International Journal of Clinical Oncology. 13(5). 395–400. 30 indexed citations

20.

Fujimoto, Yasuhisa, Keiko Murase, Hidemi Kawajiri, et al.. (2007). A case of solid neuroendocrine carcinoma of the breast in a 40-year-old Woman. Breast Cancer. 14(2). 250–253. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact